BRIEF-Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week
Reuters
Yesterday
BRIEF-Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week
Oct 17 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O:
VERTEX ANNOUNCES PROGRESS IN POVETACICEPT DEVELOPMENT PROGRAM AND PRESENTATION OF NEW DATA AT AMERICAN SOCIETY OF NEPHROLOGY KIDNEY WEEK
VERTEX PHARMACEUTICALS INC - FDA GRANTS ROLLING REVIEW FOR POVETACICEPT IN IGA NEPHROPATHY
VERTEX PHARMACEUTICALS INC: EXPECTS TO SUBMIT FIRST MODULE TO FDA FOR POTENTIAL ACCELERATED APPROVAL BEFORE END OF 2025
VERTEX PHARMACEUTICALS INC: REMAINS ON TRACK TO COMPLETE FULL BLA SUBMISSION FOR ACCELERATED APPROVAL IN U.S. IN FIRST HALF OF 2026
Source text: ID:nBw3Hntz4a
Further company coverage: VRTX.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.